Sign In
Buy BMRN
$54.66
+1.34 (+2.51%)
At Close: Jun 03, 2026
June's Biotech Boom: 3 Stocks to Buy for a Summertime Surge
06:14am, Wednesday, 05'th Jun 2024
Wall Street regards the healthcare sector as a constant source of innovation, while biotechnology stands at the pinnacle of groundbreaking medical advancements. The long-term potential of robust biote
Beacon Pointe Advisors LLC Sells 133 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
07:16am, Monday, 20'th May 2024
Beacon Pointe Advisors LLC lessened its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.7% during the fourth quarter, according to the company in its most recent
The 3 Best Biotech Stocks to Buy in May 2024
06:15am, Thursday, 09'th May 2024
We live in the best of times where life is not capped at 45 or 50 years of age, all thanks to wonderful discoveries in the field of biotechnology. The resources being invested to produce new drugs and
BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV
08:00am, Wednesday, 08'th May 2024
SAN RAFAEL, Calif. , May 8, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President, and Chief Executive Officer of BioMarin will present at th
5 Biotech Stocks Worth Adding to Your Portfolio in 2024
10:51am, Monday, 06'th May 2024
New drug approvals and pipeline progress are likely to help maintain the momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position BMRN, BPMC, IM
Investigator-Sponsored Phase 2 Study Demonstrated Positive Results in Children with Noonan Syndrome, Idiopathic Short Stature and Other Growth-Related Conditions BioMarin-Sponsored Phase 3 Data Show
Citi Just Cut Its Price Target on These 3 Stocks
02:31pm, Friday, 03'rd May 2024
Amid the current earnings season, with brokers actively revising price targets, Citigroup (NYSE: C ) recently reduced its 12-month targets for several companies. Therefore, we discuss three stocks aff
BioMarin (BMRN) Beats on Q1 Earnings, Voxzogo Drives Sales
12:50pm, Thursday, 25'th Apr 2024
BioMarin's (BMRN) earnings beat estimates in the first quarter of 2024, while revenues slightly miss the mark. The company maintains revenue guidance for 2024.
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
06:00am, Thursday, 25'th Apr 2024
If you have a high tolerance for volatility then the biotech sector might be for you. Biotech stocks can range from pre-revenue startups to global pharmaceutical giants.
BioMarin Pharmaceutical, Inc. (BMRN) Q1 2024 Earnings Call Transcript
08:50pm, Wednesday, 24'th Apr 2024
BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN ) Q1 2024 Earnings Conference Call April 24, 2024 4:30 PM ET Company Participants Traci McCarty - Head of IR Alexander Hardy - President & CEO Henry Fuchs -
BioMarin (BMRN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
07:31pm, Wednesday, 24'th Apr 2024
The headline numbers for BioMarin (BMRN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimat
BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates
06:16pm, Wednesday, 24'th Apr 2024
BioMarin Pharmaceutical (BMRN) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.60 per share. This compares to earnings of $0.60 per share a year ago.
Is a Surprise Coming for BioMarin (BMRN) This Earnings Season?
12:41pm, Tuesday, 23'rd Apr 2024
BioMarin (BMRN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Gear Up for BioMarin (BMRN) Q1 Earnings: Wall Street Estimates for Key Metrics
10:22am, Monday, 22'nd Apr 2024
Besides Wall Street's top -and-bottom-line estimates for BioMarin (BMRN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the q
BioMarin Pharmaceutical (BMRN) Expected to Beat Earnings Estimates: Should You Buy?
11:07am, Wednesday, 17'th Apr 2024
BioMarin (BMRN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
